Stage IIIC Cutaneous Melanoma AJCC v7 Recruiting Phase 0 Trials for Imiquimod (DB00724)

IndicationStatusPhase
DBCOND0091049 (Stage IIIC Cutaneous Melanoma AJCC v7)Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03276832Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV MelanomaTreatment